Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/06/2014US20140066881 Cardiac resuscitation methods and kits
03/06/2014US20140066866 Method for handling adhesive laminate sections
03/06/2014US20140066865 Patch preparation
03/06/2014US20140066843 Microneedle devices and methods
03/06/2014US20140066842 Microneedle devices and methods
03/06/2014US20140066618 Method Of Forming An Aerosol For Inhalation Delivery
03/06/2014US20140066522 Emulsions of perfluorocarbons
03/06/2014US20140066511 Topical delivery of l-arginine to cause beneficial effects
03/06/2014US20140066505 Utilization of Dialkylfumarates
03/06/2014US20140066502 Use of Stabilized Granules Containing Glyceryl Trinitrate for Arteriogenesis
03/06/2014US20140066473 Modified release compositions comprising tacrolimus
03/06/2014US20140066452 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
03/06/2014US20140066441 Aerosolized fluoroquinolones and uses thereof
03/06/2014US20140066440 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
03/06/2014US20140066389 Method and pharmaceutical to treat spinal discs
03/06/2014US20140065244 Spray Method and Composition for Reducing Psychological Hunger
03/06/2014US20140065234 Polymersomes, liposomes, and other species associated with fluidic droplets
03/06/2014US20140065233 Injectable microspheres for dermal augmentation and tissue bulking
03/06/2014US20140065232 Controlled release pharmaceutical compositions for acid-labile drugs
03/06/2014US20140065231 Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
03/06/2014US20140065230 Multiparticulate l-menthol formulations and related methods
03/06/2014US20140065229 Hydrophobic and hydrophylic aerogels encapsulated with peg hydrogel via surface initiated photopolymerization
03/06/2014US20140065225 Modified release compositions comprising tacrolimus
03/06/2014US20140065224 Crystalline n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
03/06/2014US20140065221 Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
03/06/2014US20140065217 Multilayer tablet
03/06/2014US20140065216 Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder
03/06/2014US20140065215 Controlled release pharmaceutical formulations of nitazoxanide
03/06/2014US20140065214 Delayed-release glucocorticoid treatment of rheumatoid disease
03/06/2014US20140065213 Sustained Release Paracetamol Formulations
03/06/2014US20140065212 Coated pharmaceutical composition containing regorafenib
03/06/2014US20140065211 Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
03/06/2014US20140065210 Protein stabilized probiotics and personal care products
03/06/2014US20140065204 Compositions and methods for delivering nucleic acid to a cell
03/06/2014US20140065202 Composite film
03/06/2014US20140065198 Medical Implants and Methods for Regulating the Tissue Response to Vascular Closure Devices
03/06/2014US20140065192 Sour gelled emulsions
03/06/2014US20140065191 Topical pharmaceutical composition comprising nanonized silver sulfadiazine
03/06/2014US20140065189 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
03/06/2014US20140065115 Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
03/06/2014US20140065106 Blood Plasma Based Hydrogels for Tissue Regeneration and Wound Healing Applications
03/06/2014US20140065093 Compositions For Achieving A Therapeutic Effect In An Anatomical Structure
03/06/2014US20140065061 Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
03/06/2014US20140060532 Aerosol Forming Device For Use In Inhalation Therapy
03/06/2014DE102012017225A1 Composition useful for wound disinfection, comprises polymer exhibiting polymerized methyl methacrylate units and specific glass transition temperature, polymer exhibiting polymerized methyl methacrylate units, and active substance
03/06/2014DE102012017044A1 Multi-contrast agent useful in fillers for bone and teeth, comprises particles made of sheath comprising contrast agent for computed tomography and core comprising contrast agent for magnetic resonance imaging
03/06/2014DE102012017001A1 In situ generation of dronabinol-containing aerosols for therapeutic application, by a thermal process in electric cigarette or a principally similar device from precursors such as tetrahydrocannabinolic (A and/or B) or its salts
03/06/2014CA2877525A1 Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
03/06/2014CA2877502A1 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
03/06/2014CA2854927A1 The controlled release method for a pharmaceutical composition composed of chelating complex micelles
03/05/2014EP2703411A1 NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE
03/05/2014EP2703407A1 Method for manufacturing phosphonocrotonic acid derivative
03/05/2014EP2703007A1 Antibodies with decreased deamidation profiles
03/05/2014EP2702997A1 Method and composition for enhancing target cells uptake of therapeutic agents
03/05/2014EP2702995A1 Rapidly dissolving oral tablet
03/05/2014EP2702993A1 Macrocyclic lactone compounds and methods for their use
03/05/2014EP2702989A1 Stable pharmaceutical composition
03/05/2014EP2702984A1 Drug-containing patch for treating local symptoms
03/05/2014EP2702983A1 Process for the preparation of a bispyridiniumalkane-containing semisolid preparation
03/05/2014EP2702980A2 Lotion composition for personal use
03/05/2014EP2702968A1 A patch comprising a three layer support
03/05/2014EP2702878A1 Powdered starting material, bottle cap, and container comprising said bottle cap
03/05/2014EP2702079A1 Amphoteric materials based on crosslinked hyaluronic acid, method of preparation thereof, materials containing entrapped active agents, method of preparation thereof, and use of said materials
03/05/2014EP2701753A1 Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
03/05/2014EP2701739A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
03/05/2014EP2701738A2 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
03/05/2014EP2701737A1 Tolerogenic synthetic nanocarriers for allergy therapy
03/05/2014EP2701734A2 Liposomal formulations
03/05/2014EP2701732A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
03/05/2014EP2701731A1 Intravascular delivery of nanoparticle compositions and uses thereof
03/05/2014EP2701727A2 Locally released growth factors to mediate motor recovery after stroke
03/05/2014EP2701706A2 Tolerogenic synthetic nanocarriers
03/05/2014EP2701705A2 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
03/05/2014EP2701689A2 Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
03/05/2014EP2701688A1 Controlled release tablet of ginkgo biloba extract and procedure for obtaining it
03/05/2014EP2701687A1 Risperidone sustained release microsphere composition
03/05/2014EP2701686A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/05/2014EP2701685A2 Liposomal vancomycin for the treatment of mrsa infections
03/05/2014EP2701684A1 Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
03/05/2014EP2701683A1 Administration of iloprost as aerosol bolus
03/05/2014EP2701682A1 Solvent cast film sustained release latanoprost implant
03/05/2014EP2701681A1 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
03/05/2014EP2701680A1 Sustained release latanoprost implant
03/05/2014EP2701668A1 Layer processing for pharmaceuticals
03/05/2014EP2701667A1 Process and apparatus for obtaining a solid form of material
03/05/2014CN203458605U External-application medicine patch
03/05/2014CN203458604U Toxicity removal dressing
03/05/2014CN203458603U Release retardant liquid filling device for nifedipine sustained-release tablets
03/05/2014CN203457779U Temperature-adjustable film manufacturing equipment
03/05/2014CN103620025A Novel stabilisation method for viruses or bacteria
03/05/2014CN103620010A Semi-transparent fragrance composition
03/05/2014CN103619802A Novel lipidomimetic compounds and uses thereof
03/05/2014CN103619415A Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails
03/05/2014CN103619403A Applicator system for applying a viscous liquid to the human skin
03/05/2014CN103619382A Detachable drug delivery device
03/05/2014CN103619339A Tablet containing limaprost and ss-cyclodextrin
03/05/2014CN103619338A Intranasal benzodiazepine pharmaceutical compositions
03/05/2014CN103619335A Fast dissolving azaperone granulate formulation
03/05/2014CN103619328A Method for encapsulated therapeutic products and uses thereof
03/05/2014CN103619327A Ocular drug delivery system
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 2991